GleamWall
中文EN

RIGL RIGEL PHARMACEUTICALS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1034842 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.2%
TTM net income YoY171.1%
TTM EPS YoY159.6%
Revenue 3-yr CAGR29.6%
Net income 3-yr CAGR—

Margins

Gross margin89.6%
Operating margin26.3%
Net margin106.6%
FCF margin—
EBITDA margin27.6%

Returns

ROE109.2%
ROA80.2%
ROIC (approx.)28.7%
Asset turnover0.75x

Leverage & solvency

Liabilities / assets15.0%
Debt / equity0.00x
Current ratio2.39x
Interest coverage18.17x

Cash quality & payout

Operating cash flow / net income0.29x
Accruals ratio56.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$294.28M$179.28M
Cost of revenue$19.62M$18.65M
Gross profit$274.66M$160.63M
R&D expense$33.30M$23.38M
SG&A expense$115.90M$113.06M
Operating income$125.47M$24.19M
Interest expense$7.32M$7.92M
Pretax income$121.83M$18.37M
Income tax-$245.20M$881,000
Net income$367.02M$17.48M
EBITDA$127.88M$26.42M
EPS (basic)20.400.99
EPS (diluted)19.480.99
Weighted avg. shares (diluted)18.84M17.69M
Balance sheet
Cash & equivalents$40.58M$56.75M
Short-term investments$114.38M$20.57M
Receivables$51.76M$41.62M
Inventory$11.51M$6.00M
Current assets$240.17M$135.10M
PP&E, net$30,000$92,000
Intangibles$24.75M$27.10M
Total assets$513.59M$163.98M
Current liabilities$99.24M$63.30M
Long-term debt$52.50M$60.00M
Total debt$52.50M$60.00M
Total liabilities$122.11M$160.69M
Shareholders' equity$391.48M$3.29M
Net debt$11.92M$3.25M
Shares outstanding18.31M17.71M
Cash flow statement
Operating cash flow$75.66M$31.47M
Investing cash flow-$92.36M$4.13M
Financing cash flow$601,000-$11.64M
Depreciation & amortization$2.42M$2.23M
Stock-based compensation$12.71M$12.39M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.